These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
281 related items for PubMed ID: 16406804
21. Autocrine CXCL8-dependent invasiveness triggers modulation of actin cytoskeletal network and cell dynamics. Antonosante A, Brandolini L, d'Angelo M, Benedetti E, Castelli V, Maestro MD, Luzzi S, Giordano A, Cimini A, Allegretti M. Aging (Albany NY); 2020 Jan 27; 12(2):1928-1951. PubMed ID: 31986121 [Abstract] [Full Text] [Related]
22. Towards in situ tissue repair: human mesenchymal stem cells express chemokine receptors CXCR1, CXCR2 and CCR2, and migrate upon stimulation with CXCL8 but not CCL2. Ringe J, Strassburg S, Neumann K, Endres M, Notter M, Burmester GR, Kaps C, Sittinger M. J Cell Biochem; 2007 May 01; 101(1):135-46. PubMed ID: 17295203 [Abstract] [Full Text] [Related]
23. Actin filaments are involved in the regulation of trafficking of two closely related chemokine receptors, CXCR1 and CXCR2. Zaslaver A, Feniger-Barish R, Ben-Baruch A. J Immunol; 2001 Jan 15; 166(2):1272-84. PubMed ID: 11145710 [Abstract] [Full Text] [Related]
24. Src and FAK mediate cell-matrix adhesion-dependent activation of Met during transformation of breast epithelial cells. Hui AY, Meens JA, Schick C, Organ SL, Qiao H, Tremblay EA, Schaeffer E, Uniyal S, Chan BM, Elliott BE. J Cell Biochem; 2009 Aug 15; 107(6):1168-81. PubMed ID: 19533669 [Abstract] [Full Text] [Related]
25. Cell migration to the chemokine CXCL8: paxillin is activated and regulates adhesion and cell motility. Cohen-Hillel E, Mintz R, Meshel T, Garty BZ, Ben-Baruch A. Cell Mol Life Sci; 2009 Mar 15; 66(5):884-99. PubMed ID: 19151925 [Abstract] [Full Text] [Related]
26. Migration of renal carcinoma cells is dependent on protein kinase Cdelta via beta1 integrin and focal adhesion kinase. Brenner W, Greber I, Gudejko-Thiel J, Beitz S, Schneider E, Walenta S, Peters K, Unger R, Thüroff JW. Int J Oncol; 2008 May 15; 32(5):1125-31. PubMed ID: 18425341 [Abstract] [Full Text] [Related]
27. Differential activation and regulation of CXCR1 and CXCR2 by CXCL8 monomer and dimer. Nasser MW, Raghuwanshi SK, Grant DJ, Jala VR, Rajarathnam K, Richardson RM. J Immunol; 2009 Sep 01; 183(5):3425-32. PubMed ID: 19667085 [Abstract] [Full Text] [Related]
28. FAK phosphorylation at Ser-843 inhibits Tyr-397 phosphorylation, cell spreading and migration. Jacamo R, Jiang X, Lunn JA, Rozengurt E. J Cell Physiol; 2007 Feb 01; 210(2):436-44. PubMed ID: 17096371 [Abstract] [Full Text] [Related]
29. Development of a systemically-active dual CXCR1/CXCR2 allosteric inhibitor and its efficacy in a model of transient cerebral ischemia in the rat. Garau A, Bertini R, Mosca M, Bizzarri C, Anacardio R, Triulzi S, Allegretti M, Ghezzi P, Villa P. Eur Cytokine Netw; 2006 Mar 01; 17(1):35-41. PubMed ID: 16613761 [Abstract] [Full Text] [Related]
30. Neutrophil chemotaxis caused by chronic obstructive pulmonary disease alveolar macrophages: the role of CXCL8 and the receptors CXCR1/CXCR2. Kaur M, Singh D. J Pharmacol Exp Ther; 2013 Oct 01; 347(1):173-80. PubMed ID: 23912333 [Abstract] [Full Text] [Related]
31. Cbl and Akt regulate CXCL8-induced and CXCR1- and CXCR2-mediated chemotaxis. Lane HC, Anand AR, Ganju RK. Int Immunol; 2006 Aug 01; 18(8):1315-25. PubMed ID: 16798838 [Abstract] [Full Text] [Related]
32. Osteopontin increases migration and MMP-9 up-regulation via alphavbeta3 integrin, FAK, ERK, and NF-kappaB-dependent pathway in human chondrosarcoma cells. Chen YJ, Wei YY, Chen HT, Fong YC, Hsu CJ, Tsai CH, Hsu HC, Liu SH, Tang CH. J Cell Physiol; 2009 Oct 01; 221(1):98-108. PubMed ID: 19475568 [Abstract] [Full Text] [Related]
33. Dynamic regulation of CXCR1 and CXCR2 homo- and heterodimers. Martínez Muñoz L, Lucas P, Navarro G, Checa AI, Franco R, Martínez-A C, Rodríguez-Frade JM, Mellado M. J Immunol; 2009 Dec 01; 183(11):7337-46. PubMed ID: 19890050 [Abstract] [Full Text] [Related]
34. Expression of chemokine receptors CXCR1 and CXCR2 during cardiopulmonary bypass. Chishti AD, Dark JH, Kesteven P, Powell H, Snowden C, Shenton BK, Kirby JA, Baudouin SV. J Thorac Cardiovasc Surg; 2001 Dec 01; 122(6):1162-6. PubMed ID: 11726891 [Abstract] [Full Text] [Related]
35. Identification and characterization of a new interleukin-8 receptor in bovine species. Lahouassa H, Rainard P, Caraty A, Riollet C. Mol Immunol; 2008 Feb 01; 45(4):1153-64. PubMed ID: 17727952 [Abstract] [Full Text] [Related]
36. Cross-desensitization among CXCR1, CXCR2, and CCR5: role of protein kinase C-epsilon. Nasser MW, Marjoram RJ, Brown SL, Richardson RM. J Immunol; 2005 Jun 01; 174(11):6927-33. PubMed ID: 15905535 [Abstract] [Full Text] [Related]
37. Widely expressed transcripts for chemokine receptor CXCR1 in identified glutamatergic, gamma-aminobutyric acidergic, and cholinergic neurons and astrocytes of the rat brain: a single-cell reverse transcription-multiplex polymerase chain reaction study. Danik M, Puma C, Quirion R, Williams S. J Neurosci Res; 2003 Oct 15; 74(2):286-95. PubMed ID: 14515358 [Abstract] [Full Text] [Related]
38. Combined anti CXC receptors 1 and 2 therapy is a promising anti-inflammatory treatment for respiratory diseases by reducing neutrophil migration and activation. Planagumà A, Domènech T, Pont M, Calama E, García-González V, López R, Aulí M, López M, Fonquerna S, Ramos I, de Alba J, Nueda A, Prats N, Segarra V, Miralpeix M, Lehner MD. Pulm Pharmacol Ther; 2015 Oct 15; 34():37-45. PubMed ID: 26271598 [Abstract] [Full Text] [Related]
39. Downmodulation of CXCL8/IL-8 receptors on neutrophils after recruitment in the airways. Pignatti P, Moscato G, Casarini S, Delmastro M, Poppa M, Brunetti G, Pisati P, Balbi B. J Allergy Clin Immunol; 2005 Jan 15; 115(1):88-94. PubMed ID: 15637552 [Abstract] [Full Text] [Related]
40. Functional activity of CXCL8 receptors, CXCR1 and CXCR2, on human malignant melanoma progression. Gabellini C, Trisciuoglio D, Desideri M, Candiloro A, Ragazzoni Y, Orlandi A, Zupi G, Del Bufalo D. Eur J Cancer; 2009 Sep 15; 45(14):2618-27. PubMed ID: 19683430 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]